EUVIMEDEUVIMED entdecken
Crossref

The APC/C adaptor Cdh1 stabilizes STING to potentiate innate immune activation in renal cell carcinoma

Zhichuan Zhu iD, Quentin Hahn iD, Lila E Turbiville iD, Pengda Liu iD

Science Signaling · 23.06.2026 · 19 (943)

DOI: 10.1126/scisignal.aef1474 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Signaling, erschienen am 23.06.2026. Verfasst von Zhichuan Zhu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Immunity, Innate, Membrane Proteins. Die Arbeit nennt 38 Literaturangaben. Gefördert von: U.S. Department of Defense, The University of North Carolina at Chapel Hill University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The E3 ubiquitin ligase APC/C with its coactivator Cdh1 is generally considered to be a tumor suppressor, regulating genome stability and the G 1 /S transition of the cell cycle. Cdh1 enhances the stability of immune-cell checkpoint ligand PD-L1 to modulate adaptive immunity. Here, we explored its role in innate immune regulation and identified a noncanonical, degradation-independent function of Cdh1 in clear cell renal cell carcinoma (ccRCC) through its stabilization of the cytosolic double-stranded DNA (dsDNA) sensor STING. Protein levels of Cdh1 and STING were concurrently increased in ccRCC samples from patients, and Cdh1 depletion reduced the abundance and half-life of STING protein in ccRCC cell lines. Mechanistically, Cdh1 bound to the destruction-box degron motif of STING, which sterically prevented the binding of the E3 ubiquitin ligase SPOP, thereby protecting STING from degradation. Upon stimulation of STING with an agonist or dsDNA, Cdh1 bound to STING at the Golgi and increased its abundance and signaling activity. Pharmacologically inhibiting kinases that phosphorylate Cdh1 increased STING abundance and STING-mediated type 1 interferon signaling in ccRCC cells, presumably by promoting the formation of APC/C-Cdh1-STING complexes. These findings reveal a Cdh1-STING axis in ccRCC that might be therapeutically exploited to potentiate antitumor innate immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsImmunity, InnateMembrane ProteinsAntigens, CDCdh1 ProteinsHumansSTING ProteinCell Line, TumorcGAS-STING Signaling PathwayAnimalsCadherins

Substanzen

STING ProteinCDH1 protein, humanMembrane ProteinsSTING1 protein, humanAntigens, CDCdh1 ProteinsCadherins

Autor:innen und Institutionen

  • Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Department of Environmental and Civil Engineering, Mercer University, Macon, GA 31207, USA.

ORCID-Profile: Zhichuan Zhu, Quentin Hahn, Lila E Turbiville, Pengda Liu

Förderung

  • U.S. Department of Defense
  • The University of North Carolina at Chapel Hill University

Zitieren

APA

Zhu, Z., Hahn, Q., Turbiville, L. E., & Liu, P. (2026). The APC/C adaptor Cdh1 stabilizes STING to potentiate innate immune activation in renal cell carcinoma. Science Signaling, 19(943). https://doi.org/10.1126/scisignal.aef1474

Vancouver

Zhu Z, Hahn Q, Turbiville LE, Liu P. The APC/C adaptor Cdh1 stabilizes STING to potentiate innate immune activation in renal cell carcinoma. Science Signaling. 2026;19(943). doi:10.1126/scisignal.aef1474

BibTeX
@article{Zhu2026,
  author = {Zhu, Zhichuan and Hahn, Quentin and Turbiville, Lila E and Liu, Pengda},
  title = {The APC/C adaptor Cdh1 stabilizes STING to potentiate innate immune activation in renal cell carcinoma},
  journal = {Science Signaling},
  year = {2026},
  volume = {19},
  number = {943},
  doi = {10.1126/scisignal.aef1474}
}
Kostenlos starten →